Dr. Michael Kwak, MD

Dr. Kwak practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Kwak's NPI, 1376961326, was assigned on April 6, 2014. Dr. Kwak graduated from FIU Herbert Wertheim College of Medicine in 2014. Dr. Kwak holds Florida license ME144520.

Dr. Kwak's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Kwak's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Kwak to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kwak practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Kwak's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Kwak is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kwak's licenses on file in 2 states: Florida and California.

Dmand AI lists acute diabetes, anemia, bile duct problems, cellulitis, chest pain, circulation problems, circulatory problems in extremities and congestive heart failure among the conditions Dr. Kwak treats.

CMS data shows 895 Medicare services from Dr. Kwak across 6 procedure codes in 2024, for 184 Medicare patients. Medicare paid $58,815 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 184 Medicare patients who saw Dr. Kwak in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 3.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kwak's median patient age at 66, with 52% women.

In 2024, Dr. Kwak wrote 546 Medicare Part D claims for 181 patients. 86% of them were for generic drugs. CMS names the drug for 184 of them, across 10 drugs with 11 or more claims each, at $635 in total drug cost. In 2023, CMS named 173 claims across 11 drugs.

Dr. Kwak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Kwak from 4 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. United Therapeutics Corporation paid the most, $244.

Dr. Kwak graduated from FIU Herbert Wertheim College of Medicine in 2014.

Dr. Kwak is in network with 2 carriers, including Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.